OPL-CCL11-LPM

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOPL-CCL11-LPM
Drug Alias NameCCR3 targeting agent (Osprey)LPM (Osprey)leukocyte population modulator (Osprey)OPL-CCL11-LPM
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionC-C chemokine receptor type 3 modulators
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsprey Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsprey Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A